Report Detail

According to our (Global Info Research) latest study, the global Radiopharmaceutical for Nuclear Medicine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Radiopharmaceutical for Nuclear Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Radiopharmaceutical for Nuclear Medicine market size and forecasts, in consumption value ($ Million), 2021-2032
Global Radiopharmaceutical for Nuclear Medicine market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Radiopharmaceutical for Nuclear Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Radiopharmaceutical for Nuclear Medicine market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Radiopharmaceutical for Nuclear Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Radiopharmaceutical for Nuclear Medicine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NRG, NTP Radioisotopes, JSC Isotope, ANSTO, China National Nuclear Corporation (CNNC), IRE ELIT, Nordion, Polatom, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Radiopharmaceutical for Nuclear Medicine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Carbon-14
Technetium-99m
Iodine-131
Iodine-125
Others
Market segment by Application
Nuclear Medicine Diagnosis
Nuclear Medicine Treatment
Others
Market segment by players, this report covers
NRG
NTP Radioisotopes
JSC Isotope
ANSTO
China National Nuclear Corporation (CNNC)
IRE ELIT
Nordion
Polatom
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Radiopharmaceutical for Nuclear Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radiopharmaceutical for Nuclear Medicine, with revenue, gross margin, and global market share of Radiopharmaceutical for Nuclear Medicine from 2021 to 2026.
Chapter 3, the Radiopharmaceutical for Nuclear Medicine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Radiopharmaceutical for Nuclear Medicine market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radiopharmaceutical for Nuclear Medicine.
Chapter 13, to describe Radiopharmaceutical for Nuclear Medicine research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Radiopharmaceutical for Nuclear Medicine by Type
    • 1.3.1 Overview: Global Radiopharmaceutical for Nuclear Medicine Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Type in 2025
    • 1.3.3 Carbon-14
    • 1.3.4 Technetium-99m
    • 1.3.5 Iodine-131
    • 1.3.6 Iodine-125
    • 1.3.7 Others
  • 1.4 Global Radiopharmaceutical for Nuclear Medicine Market by Application
    • 1.4.1 Overview: Global Radiopharmaceutical for Nuclear Medicine Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Nuclear Medicine Diagnosis
    • 1.4.3 Nuclear Medicine Treatment
    • 1.4.4 Others
  • 1.5 Global Radiopharmaceutical for Nuclear Medicine Market Size & Forecast
  • 1.6 Global Radiopharmaceutical for Nuclear Medicine Market Size and Forecast by Region
    • 1.6.1 Global Radiopharmaceutical for Nuclear Medicine Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Radiopharmaceutical for Nuclear Medicine Market Size by Region, (2021-2032)
    • 1.6.3 North America Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
    • 1.6.6 South America Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 NRG
    • 2.1.1 NRG Details
    • 2.1.2 NRG Major Business
    • 2.1.3 NRG Radiopharmaceutical for Nuclear Medicine Product and Solutions
    • 2.1.4 NRG Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 NRG Recent Developments and Future Plans
  • 2.2 NTP Radioisotopes
    • 2.2.1 NTP Radioisotopes Details
    • 2.2.2 NTP Radioisotopes Major Business
    • 2.2.3 NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Product and Solutions
    • 2.2.4 NTP Radioisotopes Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 NTP Radioisotopes Recent Developments and Future Plans
  • 2.3 JSC Isotope
    • 2.3.1 JSC Isotope Details
    • 2.3.2 JSC Isotope Major Business
    • 2.3.3 JSC Isotope Radiopharmaceutical for Nuclear Medicine Product and Solutions
    • 2.3.4 JSC Isotope Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 JSC Isotope Recent Developments and Future Plans
  • 2.4 ANSTO
    • 2.4.1 ANSTO Details
    • 2.4.2 ANSTO Major Business
    • 2.4.3 ANSTO Radiopharmaceutical for Nuclear Medicine Product and Solutions
    • 2.4.4 ANSTO Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 ANSTO Recent Developments and Future Plans
  • 2.5 China National Nuclear Corporation (CNNC)
    • 2.5.1 China National Nuclear Corporation (CNNC) Details
    • 2.5.2 China National Nuclear Corporation (CNNC) Major Business
    • 2.5.3 China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Product and Solutions
    • 2.5.4 China National Nuclear Corporation (CNNC) Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 China National Nuclear Corporation (CNNC) Recent Developments and Future Plans
  • 2.6 IRE ELIT
    • 2.6.1 IRE ELIT Details
    • 2.6.2 IRE ELIT Major Business
    • 2.6.3 IRE ELIT Radiopharmaceutical for Nuclear Medicine Product and Solutions
    • 2.6.4 IRE ELIT Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 IRE ELIT Recent Developments and Future Plans
  • 2.7 Nordion
    • 2.7.1 Nordion Details
    • 2.7.2 Nordion Major Business
    • 2.7.3 Nordion Radiopharmaceutical for Nuclear Medicine Product and Solutions
    • 2.7.4 Nordion Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Nordion Recent Developments and Future Plans
  • 2.8 Polatom
    • 2.8.1 Polatom Details
    • 2.8.2 Polatom Major Business
    • 2.8.3 Polatom Radiopharmaceutical for Nuclear Medicine Product and Solutions
    • 2.8.4 Polatom Radiopharmaceutical for Nuclear Medicine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Polatom Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Radiopharmaceutical for Nuclear Medicine Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Radiopharmaceutical for Nuclear Medicine by Company Revenue
    • 3.2.2 Top 3 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
    • 3.2.3 Top 6 Radiopharmaceutical for Nuclear Medicine Players Market Share in 2025
  • 3.3 Radiopharmaceutical for Nuclear Medicine Market: Overall Company Footprint Analysis
    • 3.3.1 Radiopharmaceutical for Nuclear Medicine Market: Region Footprint
    • 3.3.2 Radiopharmaceutical for Nuclear Medicine Market: Company Product Type Footprint
    • 3.3.3 Radiopharmaceutical for Nuclear Medicine Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Radiopharmaceutical for Nuclear Medicine Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Radiopharmaceutical for Nuclear Medicine Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Radiopharmaceutical for Nuclear Medicine Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Radiopharmaceutical for Nuclear Medicine Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
  • 6.2 North America Radiopharmaceutical for Nuclear Medicine Market Size by Application (2021-2032)
  • 6.3 North America Radiopharmaceutical for Nuclear Medicine Market Size by Country
    • 6.3.1 North America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
    • 6.3.2 United States Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
  • 7.2 Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
  • 7.3 Europe Radiopharmaceutical for Nuclear Medicine Market Size by Country
    • 7.3.1 Europe Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 7.3.3 France Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Market Size by Region
    • 8.3.1 Asia-Pacific Radiopharmaceutical for Nuclear Medicine Consumption Value by Region (2021-2032)
    • 8.3.2 China Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 8.3.5 India Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
  • 9.2 South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
  • 9.3 South America Radiopharmaceutical for Nuclear Medicine Market Size by Country
    • 9.3.1 South America Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Market Size by Country
    • 10.3.1 Middle East & Africa Radiopharmaceutical for Nuclear Medicine Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Radiopharmaceutical for Nuclear Medicine Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Radiopharmaceutical for Nuclear Medicine Market Drivers
  • 11.2 Radiopharmaceutical for Nuclear Medicine Market Restraints
  • 11.3 Radiopharmaceutical for Nuclear Medicine Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Radiopharmaceutical for Nuclear Medicine Industry Chain
  • 12.2 Radiopharmaceutical for Nuclear Medicine Upstream Analysis
  • 12.3 Radiopharmaceutical for Nuclear Medicine Midstream Analysis
  • 12.4 Radiopharmaceutical for Nuclear Medicine Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Radiopharmaceutical for Nuclear Medicine. Industry analysis & Market Report on Radiopharmaceutical for Nuclear Medicine is a syndicated market report, published as Global Radiopharmaceutical for Nuclear Medicine Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Radiopharmaceutical for Nuclear Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report